Traws Pharma, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.22 | $-0.16 | +27.3% | Beat |
| Q12026 FY2026 | $-0.92 | $-0.53 | +42.4% | Beat |
| Q42025 FY2025 | — | $-0.71 | — | Miss |
Back to TRAW overview · TRAW holders · TRAW KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.